news
Fabry disease treatment market value to reach $1.25b by 2024
6 August 2015 | By Victoria White
The global treatment market for Fabry disease will expand in value from $683 million in 2014 to approximately $1.25 billion by 2024...
List view / Grid view
Drug Markets
news
Atezolizumab could spur bladder cancer treatment innovation
28 July 2015 | By Victoria White
Atezolizumab is poised to become a major bladder cancer therapy in the race for FDA approval, following its promising performance in recent Phase II trials...
news
J&J and Norvatis to fight it out in the axSpA treatment space
22 July 2015 | By Victoria White
Stelara has progressed into Phase III development for axSpA and, following its anticipated approval, is forecast to achieve sales of $244.7 million in 2024...
news
HerpV and GEN-003 will drive genital herpes treatment market growth to 2023
21 July 2015 | By Victoria White
The global market value for genital herpes therapeutics will increase from approximately $490 million in 2013 to just under $668 million by 2023, largely driven by the introduction of therapeutic vaccines, HerpV and GEN-003, towards the end of the forecast period, says research and consulting firm GlobalData.
news
Soliris could drive myasthenia gravis treatment market value beyond $550 million by 2024, says GlobalData
14 July 2015 | By Victoria White
The global market for myasthenia gravis therapeutics is anticipated to more than treble in value from $146.4 million in 2014 to $550.4 million by 2024...
news
Recent drug approvals will boost Parkinson’s disease therapeutics market
2 July 2015 | By Victoria White
The Parkinson’s disease treatment market value across eight major countries will reach $4.7 billion by 2022, says GlobalData...
news
Global gene therapy deals sky-rocketed to nearly $5 billion in 2014, says GlobalData
26 June 2015 | By Victoria White
The number of deals in the global gene therapy market more than doubled in 2014, with their combined value rising spectacularly to $4.9...
news
Viscosupplementation market value to exceed $2.6 billion by 2021, says GlobalData
25 June 2015 | By Victoria White
The viscosupplementation market value will increase to a little under $2.64 billion by 2021, across the ten major markets, says GlobalData...
news
Bristol-Myers Squibb will win big with melanoma combination immunotherapy
23 June 2015 | By Victoria White
Data presented at ASCO 2015 suggests that the Opdivo/Yervoy combination of immunotherapies to treat metastatic melanoma will shape the therapeutic landscape...
news
Axial spondyloarthritis treatment market value will almost double by 2024
11 June 2015 | By Victoria White
The global market value for axial spondyloarthritis therapeutics will expand from $1.5 billion in 2014 to reach $2.9 billion by 2024...
news
Glaucoma treatment market value will grow moderately to $3 billion by 2023
10 June 2015 | By Victoria White
The treatment market for glaucoma will rise in value from $2.4 billion in 2013 to approximately $3 billion by 2023 across the seven major markets...
news
North American pharmaceutical market focus shifting from prescriber to payer, says GlobalData
9 June 2015 | By Victoria White
Cost-containment measures are shifting the decision-making focus of North America’s pharmaceutical market from the prescriber to the payer, says GlobalData...
news
Global advanced wound dressings market value to reach $3.51 billion by 2021, says GlobalData
27 May 2015 | By Victoria White
The global market value for advanced wound dressings will increase to reach $3.51 billion by 202, according to research and consulting firm GlobalData...
news
Promising malaria and dengue vaccines alone will not defeat diseases, says GlobalData Analyst
21 May 2015 | By Victoria White
Despite optimism surrounding new dengue and a malaria vaccines, vaccination alone is not a long-term solution for combatting these diseases, says GlobalData...
news
Dyslipidemia treatment market value will approach $38 billion by 2023
20 May 2015 | By Victoria White
The global treatment market for dyslipidemia will more than double from $15.4 billion in 2013 to an estimated $37.9 billion by 2023, according to GlobalData...
